Government prescription drug pricing policy and the interplay with investment in life sciences

13 Jul 2023 1500 - 1600 BST

Read more Read less
A webinar presented by the IBA Healthcare and Life Sciences Law Committee

New prescription drugs and biologics have the potential to help patients around the world. In this webinar, the speakers will each share a brief overview of key attributes and updates relating to their region’s approach to the pricing of medicine.

The speakers will consider how updated government policies are impacting:

  • the direction of scientific research; and
  • investment by private and public entities.

This topic is important no matter where a company is located. We are now witnessing the seismic impact of new strategies by governments to reign in prices for prescription drugs and biologics.

Join the panel for this timely discussion about how policies around the world are transforming how the life sciences industry values products and assesses which products warrant continued research and development.

Not only does this topic directly impact our clients, but it also directly affects each and every one of us. The policies in effect today will have a long-lasting impact on which medical conditions will be prioritised for research and ultimately whether there will be effective treatments to treat illness and cure disease.


  Prices in GBP + UK VAT @ 20%, where applicable:

IBA member


Non members


Certificate of Attendance

Certificates of attendance for each session will be provided, automatically, to all delegates who have registered in advance and attended the live broadcast for a minimum of 30 minutes based on verified sign-in and sign-out times. Certificates can only be issued to the name provided at the time of registration. If you have any queries relating to your Certificate of Attendance, please email webinars@int-bar.org

Linda Reig

Buchanan Ingersoll & Rooney, Newark, New Jersey, USA; Discussion Forum Moderator, Healthcare and Life Sciences Law Committee

Confirmed speakers
Tim Wilsdon

Charles River Associates, London, England

Kristin Wall

Norton Rose Fulbright, Toronto, Ontario, Canada

Read biography
Feng Zhou

JunHe LLP, Shanghai, China; Membership Officer, Healthcare and Life Sciences Law Committee

Read biography
Sally Shorthose

Bird & Bird, London, England

Watch webinar